Ashland Inc. (ASH) key performance indicators and operating metrics (23 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Life Sciences Sales | 172M | FY2026-Q2 |
| Specialty Additives Sales | 134M | FY2026-Q2 |
| Intermediates Sales | 35M | FY2026-Q2 |
| Personal Care Sales | 150M | FY2026-Q2 |
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization | 98M | FY2026-Q2 |
| Adjusted Income from Continuing Operations Excluding Intangible Amortization | 42M | FY2026-Q2 |
| Ongoing Free Cash Flow | 29M | FY2026-Q2 |
| Adjusted Diluted Earnings per Share Excluding Intangible Amortization | 0.91 USD_per_share | FY2026-Q2 |
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization Margin (Non-GAAP) | 20.00 percent | FY2026-Q2 |
| Adjusted Operating Income | 54M | FY2026-Q2 |
| Earnings Before Interest, Taxes, Depreciation and Amortization | 119M | FY2025-Q4 |
| Earnings Before Interest, Taxes, Depreciation and Amortization Margin | 24.90 percent | FY2025-Q4 |
| Gross Profit Margin (GAAP) | 35.80 percent | FY2025-Q4 |
| Sales Outlook | 478M | FY2025-Q4 |
Back to ASH overview · ASH earnings · ASH holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.